| Controls | Patients with IPF | |
---|---|---|---|
Serum | BALF | ||
Subjects, n | 90 | 79 | 57 |
Age, years | 53.8 ± 3.6 | 67.4 ± 8.8* | 66.5 ± 8.8* |
Sex, Male/Female | 77/13 | 70/9 | 53/4 |
Smoking history, pack-years | 16.8 ± 18.3 | 39.4 ± 28.5* | 38.3 ± 25.0* |
FVC, % predicted | 109.3 ± 16.2 | 78.7 ± 18.2* | 78.7 ± 19.2* |
DLco, % predicteda | – | 50.2 ± 16.3 | 51.2 ± 16.1 |
BALF total cell, × 104/ml | – | – | 21.9 ± 16.0 |
BALF macrophage, % | – | – | 83.4 ± 11.4 |
BALF lymphocyte, % | – | – | 11.4 ± 10.3 |
BALF neutrophil, % | – | – | 3.3 ± 3.3 |
BALF eosinophil, % | – | – | 1.9 ± 2.6 |